Información del artículo
El Texto completo está disponible en PDF
References
[1]
Marret S, Ancel PY, Marpeau L, Marchand L, Pierrat V, Larroque B, Foix-L’Hélias L, Thiriez G, Fresson J, Alberge C, Rozé JC, Matis J, Bréart G, Kaminski M. Epipage Study Group. Neonatal and 5-year outcomes after birth at 30-34 weeks of gestation. Obstet Gynecol. 2007 Jul;110(1):72-80.
[2]
N.L. González-González, V. Medina, A. Jiménez, J. Gómez Arias, A. Ruano, A. Perales, et al.
Base de datos perinatales nacionales 2004.
Prog Obstet Ginecol, 49 (2006), pp. 645-655
[3]
Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG. 2006 Dec;113 Suppl 3:17-42. Review. Erratum in: BJOG. 2008 Apr;115(5):674-5.
[4]
Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol. 2000 Jul;96(1):95-101.
[5]
Tsoi E, Akmal S, Rane S, Otigbah C, Nicolaides KH. Ultrasound assessment of cervical length in threatened preterm labor. Ultrasound Obstet Gynecol. 2003 Jun;21(6):552-5.
[6]
RCOG Green-top Guideline No.1b. Tocolysis for women in preterm labour. 2011.
[7]
Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, Roberts TE, Barton PM, Jowett SM, Hyde CJ, Khan KS. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2009 Sep;13(43):1-627.
[8]
Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29;334(9):567-72.
[9]
Berghella V, Roman A, Daskalakis C, Ness A, Baxter JK. Gestational age at cervical length measurement and incidence of preterm birth. Obstet Gynecol. 2007 Aug;110(2 Pt1):311-7.
[10]
Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003 Feb;101(2):402-12.
[11]
C.B. Wulff, C.K. Ekelund, M. Hedegaard, A. Tabor.
Can a 15-mm cervical length cutoff discriminate between low and high risk of preterm delivery in women with threatened preterm labor?.
Fetal Diagn Ther, 29 (2011), pp. 216-223
[12]
Fuchs I, Tsoi E, Henrich W, Dudenhausen JW, Nicolaides KH. Sonographic measurement of cervical length in twin pregnancies in threatened preterm labor. Ultrasound Obstet Gynecol. 2004 Jan;23(1):42-5.
[13]
Tsoi E, Fuchs IB, Rane S, Geerts L, Nicolaides KH. Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes. Ultrasound Obstet Gynecol. 2005 Apr;25(4):353-6.
[14]
Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol. 2010 Jan;35(1):54-64.
[15]
To MS, Skentou C, Liao AW, Cacho A, Nicolaides KH. Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol. 2001 Sep;18(3):200-3.
[16]
Palacio M, Sanin-Blair J, Sánchez M, Crispi F, Gómez O, Carreras E, Coll O, Cararach V, Gratacós E. The use of a variable cut-off value of cervical length in women admitted for preterm labor before and after 32 weeks. Ultrasound Obstet Gynecol. 2007 Apr;29(4):421-6.
[17]
F. Crispi, E. Llurba, C. Pedrero, E. Carreras, T. Higueras, E. Hermosilla, et al.
Curvas de normalidad de la longitud cervical ecográfica según edad gestacional en población española.
Prog Obstet Ginecol, 47 (2004), pp. 264-271
[18]
Tsoi E, Fuchs I, Henrich W, Dudenhausen JW, Nicolaides KH. Sonographic measurement of cervical length in preterm prelabor amniorrhexis. Ultrasound Obstet Gynecol. 2004 Oct;24(5):550-3.
[19]
Lim K, Butt K, Crane JM. SOGC Clinical Practice Guideline. Ultrasonographic cervical length assessment in predicting preterm birth in singleton pregnancies. J Obstet Gynaecol Can. 2011 May;33(5):486-99.
[20]
M. Ramírez, J.L. Dueñas, C. Bedoya, J. Polo.
Utilidad de la prueba de la fibronectina fetal y de la longitud del cérvix para la predicción del parto prematuro en gestantes sintomáticas.
Prog Obstet Ginecol, 52 (2009), pp. 199-205
[21]
Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol. 2009 Sep;114(3):631-40.
[22]
Gomez R, Romero R, Medina L, Nien JK, Chaiworapongsa T, Carstens M, González R, Espinoza J, Iams JD, Edwin S, Rojas I. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol. 2005 Feb;192(2):350-9. Erratum in: Am J Obstet Gynecol. 2005 Jul;193(1):308-9.
[23]
Schmitz T, Maillard F, Bessard-Bacquaert S, Kayem G, Fulla Y, Cabrol D, Goffinet F. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol. 2006 Jan;194(1):138-43.
[24]
Hincz P, Wilczynski J, Kozarzewski M, Szaflik K. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand. 2002 Jan;81(1):58-63.
[25]
Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J, Fraser WD. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour. J Obstet Gynaecol Can. 2010 Apr;32(4):307-12.
[26]
Conde-Agudelo A, Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2010 Dec;23(12):1365-76.
[27]
McPheeters ML, Miller WC, Hartmann KE, Savitz DA, Kaufman JS, Garrett JM, Thorp JM. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol. 2005 Apr;192(4):1325-9; discussion 1329-30.
[28]
Gomez R, Romero R, Nien JK, Chaiworapongsa T, Medina L, Kim YM, Yoon BH, Carstens M, Espinoza J, Iams JD, Gonzalez R. A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 2005 Mar;192(3):678-89.
[29]
Palacio M, Cobo T, Bosch J, Filella X, Navarro-Sastre A, Ribes A, Gratacós E. Cervical length and gestational age at admission as predictors of intra-amniotic inflammation in preterm labor with intact membranes. Ultrasound Obstet Gynecol. 2009 Oct;34(4):441-7.
[30]
C.M. Stan, M. Boulvain, R. Pfister, P. Hirsbrunner-Almagbaly.
Hydration for treatment of preterm labour.
Cochrane Database of Systematic Reviews, (2002), pp. CD003096
[31]
Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol. 1999 Nov;94(5 Pt 2):869-77.
[32]
Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, Perry KG, Varner M, Goodwin TM, Lane R, Smith J, Shangold G, Creasy GW. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 2000 May;182(5):1173-83.
[33]
Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol. 2009 Mar;113(3):585-94.
[34]
Hannah ME. Search for best tocolytic for preterm labour. Lancet. 2000 Aug 26;356(9231):699-700.
[35]
J.F. King, V.J. Flenady, D.N. Papatsonis, G.A. Dekker, B. Carbonne.
Calcium channel blockers for inhibiting preterm labour.
Cochrane Database Syst Rev, (2003), pp. CD002255
[36]
Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting. preterm labour. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004452.
[37]
Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for of preterm labor. Int J Gynaecol Obstet. 2005 Oct;91(1):10-4.
[38]
Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011 Feb;204(2):134.e1-20.
[39]
Coomarasamy A, Knox EM, Gee H, Khan KS. Oxytocin antagonists for tocolysis in preterm labour - a systematic review. Med Sci Monit. 2002 Nov;8(11):RA268-73.
[40]
Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006 May;40(5):824-9.
[41]
C.A. Crowther, J.E. Hiller, L.W. Doyle.
Magnesium sulphate for preventing preterm birth in threatened preterm labour.
Cochrane Database Syst Rev, (2002), pp. CD001060
[42]
de Heus R, Mol BW, Erwich JJ, van Geijn HP, Gyselaers WJ, Hanssens M, Härmark L, van Holsbeke CD, Duvekot JJ, Schobben FF, Wolf H, Visser GH. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009 Mar 5;338:b744.
[43]
S. Oei.
Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events.
Eur J Obstet Gynecol Reprod Biol, 126 (2006), pp. 137-145
[44]
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004454.
[45]
Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD003935.
[46]
RCOG Green-top Guideline No7. Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. 2010.
[47]
McKinlay CJ, Crowther CA, Middleton P, Harding JE. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am J Obstet Gynecol. 2012 Mar;206(3):187-94.
[48]
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004661.
[49]
Costantine MM, Weiner SJ. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009 Aug;114(2 Pt 1):354-64.
[50]
Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009 Jun;200(6):595-609.
[51]
Sociedad Española de Ginecología y Obstetricia. Protocolo sobre Sulfato de magnesio para la neuroprotección fetal. Diciembre 2011. Accesible en: http://bit.ly/Kq2YII.
[52]
King J, Flenady V. Antibiotics for inhibiting preterm labour with intact membranes (Cohrane Review). In: The Cohrane Library, Issue 1. Oxford Update Sofware, 2003.
[53]
Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36.
[54]
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011 Apr;117(4):1019-27.
[55]
Sociedad Española de Ginecología y Obstetricia. Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas 2012. Protocolo SEGO. Madrid 2012. Accesible en: http://bit.ly/I04nBB.
[56]
Yost NP, Bloom SL, McIntire DD, Leveno KJ. Hospitalization for women with arrested preterm labor: a randomized trial. Obstet Gynecol. 2005 Jul;106(1):14-8.
[57]
Reichmann JP. Home uterine activity monitoring: the role of medical evidence. Obstet Gynecol. 2008 Aug;112(2 Pt 1):325-7.
[58]
C. Sosa, F. Althabe, J. Belizán, E. Bergel.
Bed rest in singleton pregnancies for preventing preterm birth.
Cochrane Database Syst Rev, (2004), pp. CD003581
[59]
Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: a meta-analysis. Obstet Gynecol. 2000 Apr;95(4):623-35.
[60]
J. Kavanagh, A.J. Kelly, J. Thomas.
Sexual intercourse for cervical ripening and induction of labour.
Cochrane Database Syst Rev, (2001), pp. CD003093
[61]
Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009 Jun;200(6):595-609.
[62]
Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol. 1999 Aug;181(2):484-90.
[63]
Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003927.
[64]
N.N. Gaunekar, C.A. Crowther.
Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.
Cochrane Database Syst Rev, (2004), pp. CD004071
[65]
Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005938.
Copyright © 2012. SEGO